|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
1996-2-23
|
|
pubmed:abstractText |
Skeletal complications are a major clinical manifestation of multiple myeloma. These complications are caused by soluble factors that stimulate osteoclasts to resorb bone. Bisphosphonates such as pamidronate inhibit osteoclastic activity and reduce bone resorption.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0028-4793
|
|
pubmed:author |
pubmed-author:BallesterOO,
pubmed-author:BellRR,
pubmed-author:BerensonJ RJR,
pubmed-author:BlacklockH AHA,
pubmed-author:BordoniRR,
pubmed-author:DimopoulosM AMA,
pubmed-author:GeorgeSS,
pubmed-author:HeffernanMM,
pubmed-author:KellerAA,
pubmed-author:KnightR DRD,
pubmed-author:KovacsM JMJ,
pubmed-author:LichtensteinAA,
pubmed-author:LiptonAA,
pubmed-author:PorterLL,
pubmed-author:ReitsmaD JDJ,
pubmed-author:SeamanJJ,
pubmed-author:SimeoneJJ
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
22
|
|
pubmed:volume |
334
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
488-93
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8559201-Aged,
pubmed-meshheading:8559201-Diphosphonates,
pubmed-meshheading:8559201-Disease-Free Survival,
pubmed-meshheading:8559201-Double-Blind Method,
pubmed-meshheading:8559201-Female,
pubmed-meshheading:8559201-Fractures, Bone,
pubmed-meshheading:8559201-Humans,
pubmed-meshheading:8559201-Hypercalcemia,
pubmed-meshheading:8559201-Male,
pubmed-meshheading:8559201-Middle Aged,
pubmed-meshheading:8559201-Multiple Myeloma,
pubmed-meshheading:8559201-Osteolysis,
pubmed-meshheading:8559201-Pain,
pubmed-meshheading:8559201-Spinal Cord Compression,
pubmed-meshheading:8559201-Survival Analysis,
pubmed-meshheading:8559201-Treatment Outcome
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group.
|
|
pubmed:affiliation |
West Los Angeles Veterans Affairs Medical Center, CA 90073, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
